Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 report is an essential source of information and analysis on the global Acute Pain Therapeutics market. The report identifies the key trends shaping and driving the global Acute Pain Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Acute Pain Therapeutics sector.
Scope
The report provides information on the key drivers and challenges of the Acute Pain Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Acute Pain Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Acute Pain Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Acute Pain Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Acute Pain Therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Acute Pain Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Acute Pain Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Acute Pain Therapeutics market landscape? – Identify, understand and capitalize.
Companies Mentioned
Grunenthal QRxPharma Iroko Pharma Hospira Transdel Pharma MEDRx Co.
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/84914/acute-pain-therapeutics-pipeline-assessment-and-market-forecasts-to-2019.html
Sunday, 29 July 2012
Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019
Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019 report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines market. The report identifies the key trends shaping and driving the global Hepatitis A Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hepatitis A Preventive Vaccines sector.
Scope
The report provides information on the key drivers and challenges of the Hepatitis A Preventive Vaccines market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hepatitis A Preventive Vaccines market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Hepatitis A Preventive Vaccines market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Hepatitis A Preventive Vaccines market.
- Analysis of key recent licensing and partnership agreements in Hepatitis A Preventive Vaccines market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Hepatitis A Preventive Vaccines market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Hepatitis A Preventive Vaccines market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Hepatitis A Preventive Vaccines market landscape? – Identify, understand and capitalize.
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/84912/hepatitis-a-preventive-vaccines-pipeline-assessment-and-market-forecasts-to-2019.html
Scope
The report provides information on the key drivers and challenges of the Hepatitis A Preventive Vaccines market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hepatitis A Preventive Vaccines market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Hepatitis A Preventive Vaccines market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Hepatitis A Preventive Vaccines market.
- Analysis of key recent licensing and partnership agreements in Hepatitis A Preventive Vaccines market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Hepatitis A Preventive Vaccines market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Hepatitis A Preventive Vaccines market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Hepatitis A Preventive Vaccines market landscape? – Identify, understand and capitalize.
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/84912/hepatitis-a-preventive-vaccines-pipeline-assessment-and-market-forecasts-to-2019.html
Saturday, 28 July 2012
New Report On Healthcare, Regulatory and Reimbursement Landscape In Australia
Healthcare, Regulatory and Reimbursement Landscape in Australia report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Australia. It identifies key trends, and most importantly, provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market.
In 2010, Australia’s population was 22.4 million, largely due to a positive balance between the birth rate and mortality rate and net overseas immigration. The mortality rate is almost steady due to Australia’s strong healthcare infrastructure and medical and diagnostic services. The pharmaceutical market was estimated at $14.9 billion in 2010 and is expected to reach $30.5 billion by 2020 at a projected CAGR of 7.4%. The medical device market size was worth approximately $6.5 billion in 2011 and is expected to reach $10 billion by 2020 at a projected CAGR of 4.8%.
The positive trends in the healthcare market can be attributed primarily to -
- Easy market access to pharmaceutical drugs
- Increasing awareness of the need for the early detection of lifestyle and chronic diseases
- Government-subsidized prescription medicines through the Pharmaceutical Benefit Scheme (PBS) for all eligible, general or concessional patients
- Annual review and addition of expensive innovative drugs to the PBS drug list
Scope
The report provides information on the Australian healthcare, regulatory and reimbursement landscape, and includes -
- Overview of the pharmaceutical and medical devices market, including size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical devices market. The key players covered for the pharmaceutical market are Pfizer, AstraZeneca, Novartis, Sanofi and GlaxoSmithKline, and the key players covered for the medical devices market are Siemens Healthcare, GE Healthcare, DePuy Inc, F. Hoffmann-la Roche and Stryker Corporation.
- Insightful review of the reimbursement and regulatory landscape, with details of the healthcare reimbursement process, regulatory agencies and market authorization processes for new drug and medical devices.
- Detailed analysis of Australia’s political and economic environment, including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the healthcare market.
Reasons to buy
This report comprehensively covers both the pharmaceutical and the medical devices market in Australia. It will enhance your decision-making capability and allow you to -
- Develop business strategies by understanding the trends shaping and driving the Australian healthcare market.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market.
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/87794/healthcare-regulatory-and-reimbursement-landscape-australia.html
In 2010, Australia’s population was 22.4 million, largely due to a positive balance between the birth rate and mortality rate and net overseas immigration. The mortality rate is almost steady due to Australia’s strong healthcare infrastructure and medical and diagnostic services. The pharmaceutical market was estimated at $14.9 billion in 2010 and is expected to reach $30.5 billion by 2020 at a projected CAGR of 7.4%. The medical device market size was worth approximately $6.5 billion in 2011 and is expected to reach $10 billion by 2020 at a projected CAGR of 4.8%.
The positive trends in the healthcare market can be attributed primarily to -
- Easy market access to pharmaceutical drugs
- Increasing awareness of the need for the early detection of lifestyle and chronic diseases
- Government-subsidized prescription medicines through the Pharmaceutical Benefit Scheme (PBS) for all eligible, general or concessional patients
- Annual review and addition of expensive innovative drugs to the PBS drug list
Scope
The report provides information on the Australian healthcare, regulatory and reimbursement landscape, and includes -
- Overview of the pharmaceutical and medical devices market, including size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical devices market. The key players covered for the pharmaceutical market are Pfizer, AstraZeneca, Novartis, Sanofi and GlaxoSmithKline, and the key players covered for the medical devices market are Siemens Healthcare, GE Healthcare, DePuy Inc, F. Hoffmann-la Roche and Stryker Corporation.
- Insightful review of the reimbursement and regulatory landscape, with details of the healthcare reimbursement process, regulatory agencies and market authorization processes for new drug and medical devices.
- Detailed analysis of Australia’s political and economic environment, including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the healthcare market.
Reasons to buy
This report comprehensively covers both the pharmaceutical and the medical devices market in Australia. It will enhance your decision-making capability and allow you to -
- Develop business strategies by understanding the trends shaping and driving the Australian healthcare market.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market.
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/87794/healthcare-regulatory-and-reimbursement-landscape-australia.html
New Report On Healthcare, Regulatory and Reimbursement Landscape In South Korea
Healthcare, Regulatory and Reimbursement Landscape in South Korea report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of South Korea. The report identifies the key trends in the healthcare market of South Korea. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of South Korea. Most importantly, the report provides valuable insights on the trends and segmentation of pharmaceutical and medical devices market.
The population of South Korea has been increasing with a CAGR of 0.4% from 2005-2010. As in most developed countries, South Korea also has increasing elderly population. Approximately 16% of the total population was above the age of 65 years in 2010. Due to the increasing elderly population the pharmaceutical market is expected to grow but it has been hindering the growth of the economy. It has one of the world's highest population densities.
The pharmaceutical market grew at Compound Annual Growth Rate (CAGR) of 7% from 2005 to 2010. The market is estimated to reach $28.1 billion in 2020. This reflects significant opportunities for foreign investors and their Research and Development (R&D) partners. The market for medical devices in Korea is one of the largest markets in Asia due to the increasing elderly population and subsequent increase in the demand for healthcare products and services. The medical device market in South Korea was valued at approximately $3 billion in 2005. It grew at a CAGR of 2.8% from 2005 to 2010. The market is predicted to reach $5.7 billion by 2020.
The positive trend in the healthcare market of South Korea can be attributed primarily to -
- Increasing elderly population
- Universal healthcare insurance
- High degree of access to healthcare facilities
Scope
The report provides information on the healthcare, regulatory and reimbursement landscape of South Korea. The scope includes -
- Overview of the pharmaceutical and medical devices market of South Korea including the market size, market segmentation, key drivers and barriers for the market.
- Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market.
- Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs and medical devices for South Korea.
- A detailed analysis of the political and economic environment of South Korea including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities and challenges for growth that exist in the healthcare market of South Korea.
Reasons to buy
The report on South Korea comprehensively covers both the pharmaceutical and the medical devices market of South Korea. The report will enhance your decision making capability. It will allow you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare market of South Korea.
- Drive revenues by understanding the key trends, and reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the South Korean healthcare market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market of South Korea.
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/87793/healthcare-regulatory-and-reimbursement-landscape-south-korea.html
The population of South Korea has been increasing with a CAGR of 0.4% from 2005-2010. As in most developed countries, South Korea also has increasing elderly population. Approximately 16% of the total population was above the age of 65 years in 2010. Due to the increasing elderly population the pharmaceutical market is expected to grow but it has been hindering the growth of the economy. It has one of the world's highest population densities.
The pharmaceutical market grew at Compound Annual Growth Rate (CAGR) of 7% from 2005 to 2010. The market is estimated to reach $28.1 billion in 2020. This reflects significant opportunities for foreign investors and their Research and Development (R&D) partners. The market for medical devices in Korea is one of the largest markets in Asia due to the increasing elderly population and subsequent increase in the demand for healthcare products and services. The medical device market in South Korea was valued at approximately $3 billion in 2005. It grew at a CAGR of 2.8% from 2005 to 2010. The market is predicted to reach $5.7 billion by 2020.
The positive trend in the healthcare market of South Korea can be attributed primarily to -
- Increasing elderly population
- Universal healthcare insurance
- High degree of access to healthcare facilities
Scope
The report provides information on the healthcare, regulatory and reimbursement landscape of South Korea. The scope includes -
- Overview of the pharmaceutical and medical devices market of South Korea including the market size, market segmentation, key drivers and barriers for the market.
- Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market.
- Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs and medical devices for South Korea.
- A detailed analysis of the political and economic environment of South Korea including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities and challenges for growth that exist in the healthcare market of South Korea.
Reasons to buy
The report on South Korea comprehensively covers both the pharmaceutical and the medical devices market of South Korea. The report will enhance your decision making capability. It will allow you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare market of South Korea.
- Drive revenues by understanding the key trends, and reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the South Korean healthcare market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market of South Korea.
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/87793/healthcare-regulatory-and-reimbursement-landscape-south-korea.html
New Report On Pharmaceutical Leaders 2012 - Key Trends & Emerging Strategies
Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers Report integrates deep research of top players in the pharmaceutical industry with our proprietary analysis and ranking methodology to reveal top performers, industry trends, and the strategies that successful companies are using to stay ahead in the increasingly demanding pharmaceutical marketplace. Clients can use this report for strategic planning and tracking of competitor strategies. The report covers major drug approvals and significant M&A and license agreements, as well as other significant cost-containment and operations strategies.
Scope
- Full financial details and for the top 25 pharmaceutical companies including detailed analysis of key performance metrics.
- Analysis of the key drivers, trends, and strategies employed by leading companies across important geographic regions including the US, EU, Japan, Asia-Pacific, Brazil, Russia, India, China, and other emerging markets.
- In addition to the six major therapy areas of cardiovascular disease, central nervous system (CNS), diabetes and metabolic, immunology, oncology, and respiratory diseases, the report analyzes the leading players in the generic pharmaceuticals market.
- The report includes analysis of important events in 2010 and 2011 that drove the success of leading companies during the year.
Reasons to buy
- Analyze and emulate the strategies that successful companies are using to maintain their lead in the increasingly competitive global pharmaceutical market.
- Understand the underlying financial metrics that differentiate certain companies from the pack in terms of growth and profitability, even if they are not revenue leaders.
- Identify the important disease areas, types of products, and geographical areas where successful companies are expanding to ensure their future success.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
To view a detailed table of contents for this market report please visit:http://www.reportstack.com/product/87792/pharmaceutical-leaders-2012-key-trends-emerging-strategies-and-financial-analysis-of-the-top-performers.html
Scope
- Full financial details and for the top 25 pharmaceutical companies including detailed analysis of key performance metrics.
- Analysis of the key drivers, trends, and strategies employed by leading companies across important geographic regions including the US, EU, Japan, Asia-Pacific, Brazil, Russia, India, China, and other emerging markets.
- In addition to the six major therapy areas of cardiovascular disease, central nervous system (CNS), diabetes and metabolic, immunology, oncology, and respiratory diseases, the report analyzes the leading players in the generic pharmaceuticals market.
- The report includes analysis of important events in 2010 and 2011 that drove the success of leading companies during the year.
Reasons to buy
- Analyze and emulate the strategies that successful companies are using to maintain their lead in the increasingly competitive global pharmaceutical market.
- Understand the underlying financial metrics that differentiate certain companies from the pack in terms of growth and profitability, even if they are not revenue leaders.
- Identify the important disease areas, types of products, and geographical areas where successful companies are expanding to ensure their future success.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
To view a detailed table of contents for this market report please visit:http://www.reportstack.com/product/87792/pharmaceutical-leaders-2012-key-trends-emerging-strategies-and-financial-analysis-of-the-top-performers.html
New Report On Planned LNG Terminals Market - Global Analysis, Competitive Landscape
Planned LNG Terminals Market - Global Analysis, Competitive Landscape and Capacity Forecasts to 2017 is the latest report that analyses the planned LNG terminals market with the competitive landscape and capacity forecasts to 2017. The report provides information about the planned LNG liquefaction and regasification markets during 2012-2017. The report gives a detailed information on the planned LNG terminals that will commence operations globally by 2017, the major countries accounting for the LNG capacity additions and the dominating companies in the liquefaction and regasification capacity additions.. The report also provides key issues and challenges for the industry in the current industry environment.
Scope
This report provides detailed analysis of the planned LNG terminals market with the competitive landscape and capacity forecasts to 2017. The report primarily focuses on -
- Issues and challenges for planned LNG markets
- Major contribution towards LNG liquefaction capacity additions from the top countries
- Major contribution towards LNG liquefaction capacity additions from the top companies
- Major contribution towards LNG regasification capacity additions from the top countries
- Major contribution towards LNG regasification capacity additions from the top companies
- Competitive analysis taking into account the global LNG liquefaction capacity additions by top five companies
- Competitive analysis taking into account the global LNG regasification capacity additions by top five companies
Reasons to buy
The report will enhance your decision-making capability. It will allow you to -
- Develop business strategies with the help of specific insights into the planned LNG liquefaction and regasification markets.
- Identify opportunities and challenges in the LNG liquefaction and regasification markets.
- Plan your strategies based on expected developments in the global LNG market.
- Understand the competitive landscape of this emerging LNG market.
- Keep yourself informed of the key developments in this potential planned LNG market.
Keywords
Global Planned LNG terminals, planned LNG liquefaction capacity, planned LNG regasification capacity, key planned LNG terminals, LNG capacities by countries and companies
Companies Mentioned
Chevron Corporation Southern Union Company Corpus Christi Liquefaction, LLC Freeport LNG Development, L.P. Sempra Energy ConocoPhillips Queensland Gas Co. Ltd. Inpex Corporation
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/87767/planned-lng-terminals-market-global-analysis-competitive-landscape-and-capacity-forecasts-to-2017.html
Scope
This report provides detailed analysis of the planned LNG terminals market with the competitive landscape and capacity forecasts to 2017. The report primarily focuses on -
- Issues and challenges for planned LNG markets
- Major contribution towards LNG liquefaction capacity additions from the top countries
- Major contribution towards LNG liquefaction capacity additions from the top companies
- Major contribution towards LNG regasification capacity additions from the top countries
- Major contribution towards LNG regasification capacity additions from the top companies
- Competitive analysis taking into account the global LNG liquefaction capacity additions by top five companies
- Competitive analysis taking into account the global LNG regasification capacity additions by top five companies
Reasons to buy
The report will enhance your decision-making capability. It will allow you to -
- Develop business strategies with the help of specific insights into the planned LNG liquefaction and regasification markets.
- Identify opportunities and challenges in the LNG liquefaction and regasification markets.
- Plan your strategies based on expected developments in the global LNG market.
- Understand the competitive landscape of this emerging LNG market.
- Keep yourself informed of the key developments in this potential planned LNG market.
Keywords
Global Planned LNG terminals, planned LNG liquefaction capacity, planned LNG regasification capacity, key planned LNG terminals, LNG capacities by countries and companies
Companies Mentioned
Chevron Corporation Southern Union Company Corpus Christi Liquefaction, LLC Freeport LNG Development, L.P. Sempra Energy ConocoPhillips Queensland Gas Co. Ltd. Inpex Corporation
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/87767/planned-lng-terminals-market-global-analysis-competitive-landscape-and-capacity-forecasts-to-2017.html
New Report On Gas Shales in Europe, 2012 - Market Analysis & Industry Development
Gas Shales in Europe, 2012 - Market Analysis, Industry Development and Competitive Landscape, is the latest report f analyzing shale gas prospects and developments in Europe. The report provides information about Europe’s current shale gas market, and gives information on the European natural gas industry, the region’s shale gas reserves and their contribution to the international markets. Natural gas has been an important resource for Europe, especially with the steady rise in its natural gas demand over many years. Currently, Europe’s consumption for natural gas surpasses the region’s domestic production, and is higher than twice the region’s gas production. This has led to increased imports mostly from Russia, Norway, Algeria and Qatar. This increased dependency on imports has led to a drive within Europe to seek alternative sources of natural gas and shale gas, the latter of which, in this scenario, has emerged as a lucrative option.
Scope
This report provides analysis of the shale gas markets in Europe, key companies and the key trends and issues in the industry. The report primarily focuses on -
- Shale gas reserves in Europe
- Key companies engaged in shale gas development in Europe
- Key exploration projects in Polish shale basins
- Key issues and trends in shale gas development in Europe
- Competitive landscape of the European shale gas market
Reasons to buy
The report will allow you to make decisions in a more rapid and time sensitive manner. It will allow you to -
- Understand the market positioning of the major shale gas countries and companies in Europe
- Identify opportunities and challenges in European shale gas market
- Develop business strategies with the help of specific insights about the second most important shale destination in the world
- Identify business opportunities through comprehensive knowledge about activities taken up by companies in Europe, especially Poland, for shale development.
Keywords
Europe Shale gas. Poland shale gas, Eastern Europe shale gas, Western Europe shale gas
Companies Mentioned
3Legs Resources PLC BNK Petroleum Inc. Chevron Corporation Cuadrilla Resources Ltd. ConocoPhillips ENI S.p.A. ExxonMobil Corporation* Hutton Energy LNG Energy Ltd. Marathon Oil Corporation Mouvoil Sa RWE Dea AG San Leon Energy Schuepbach Energy LLC Talisman Energy Inc. Total S.A. Tethys Oil AB Marathon Oil Corporation* Lane Energy Poland BNK Petroleum Inc. (Indiana Investments) BNK Petroleum Inc. (Saponis Investments) ConocoPhillips* Talisman Energy Inc. Cuadrilla Resources Ltd. Hutton Energy PLC San Leon Energy PLC
To view a detailed table of contents for this market report please visit:http://www.reportstack.com/product/87766/gas-shales-in-europe-2012-market-analysis-industry-development-and-competitive-landscape.html
Scope
This report provides analysis of the shale gas markets in Europe, key companies and the key trends and issues in the industry. The report primarily focuses on -
- Shale gas reserves in Europe
- Key companies engaged in shale gas development in Europe
- Key exploration projects in Polish shale basins
- Key issues and trends in shale gas development in Europe
- Competitive landscape of the European shale gas market
Reasons to buy
The report will allow you to make decisions in a more rapid and time sensitive manner. It will allow you to -
- Understand the market positioning of the major shale gas countries and companies in Europe
- Identify opportunities and challenges in European shale gas market
- Develop business strategies with the help of specific insights about the second most important shale destination in the world
- Identify business opportunities through comprehensive knowledge about activities taken up by companies in Europe, especially Poland, for shale development.
Keywords
Europe Shale gas. Poland shale gas, Eastern Europe shale gas, Western Europe shale gas
Companies Mentioned
3Legs Resources PLC BNK Petroleum Inc. Chevron Corporation Cuadrilla Resources Ltd. ConocoPhillips ENI S.p.A. ExxonMobil Corporation* Hutton Energy LNG Energy Ltd. Marathon Oil Corporation Mouvoil Sa RWE Dea AG San Leon Energy Schuepbach Energy LLC Talisman Energy Inc. Total S.A. Tethys Oil AB Marathon Oil Corporation* Lane Energy Poland BNK Petroleum Inc. (Indiana Investments) BNK Petroleum Inc. (Saponis Investments) ConocoPhillips* Talisman Energy Inc. Cuadrilla Resources Ltd. Hutton Energy PLC San Leon Energy PLC
To view a detailed table of contents for this market report please visit:http://www.reportstack.com/product/87766/gas-shales-in-europe-2012-market-analysis-industry-development-and-competitive-landscape.html
Subscribe to:
Posts (Atom)